Chugai Pharmaceutical Co Ltd

4519: XTKS (JPN)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|%rRLOCK|>?Y<mLOCK|^m@h#?$

Chugai Earnings: Full-Year Guidance Reiterated as Chugai Makes Steady Progress

Revenue for the quarter was JPY 290 billion and operating profit was JPY 136.7 billion, which are 8% and 14% year-on-year declines.

Sponsor Center